{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:31:55Z","timestamp":1786422715019,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prior studies examining the relationship between coronavirus disease 2019 (COVID-19) and thyroid cancer in general populations may be influenced by surveillance bias, complicating interpretation of their findings. To address this limitation, we evaluated the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and incident thyroid cancer specifically among adults with pre-existing thyroid disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the TriNetX Global Collaborative Network to conduct a propensity score\u2013matched cohort study of adults aged \u226518 years with thyroid disorders between 2020 and 2022. Patients with documented COVID-19 were compared with matched controls without recorded SARS-CoV-2 infection. A 24-month landmark design excluded cancers diagnosed during early post-infectious evaluation. The primary outcome was incident thyroid cancer, estimated using Cox proportional hazards models, and all-cause mortality was assessed as a secondary outcome. Follicular cysts of skin served as a negative-control outcome. E-values were calculated to assess the robustness of the observed association to potential unmeasured confounding. Sensitivity, subgroup, alternative landmark, hospitalization-based severity-stratified, competing-risk, and secondary generalizability analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After matching, 603,364 patients were included in each cohort. COVID-19 was associated with a higher risk of incident thyroid cancer (hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.49\u20131.75; E-value, 2.60). The association persisted across sensitivity analyses (HRs, 1.70\u20131.95), sex and age strata, baseline thyroid-disease subtypes, hospitalization status, and 1- to 3-year landmark analyses. Similar findings were observed in a secondary cohort of adults with type 2 diabetes and no prior thyroid disease (HR, 1.78; 95% CI, 1.53\u20132.07). All-cause mortality was higher in the COVID-19 cohort compared with controls (HR, 1.70; 95% CI, 1.66\u20131.73). The negative-control outcome showed no increase in cumulative incidence (risk ratio, 0.95) despite a modestly higher hazard (HR, 1.16; 95% CI, 1.13\u20131.19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among adults with pre-existing thyroid disease, COVID-19 was associated with a delayed increase in incident thyroid cancer. This association was not readily explained by measured healthcare utilization alone, but residual surveillance bias cannot be excluded. These findings represent an epidemiologic signal rather than proof of causation and do not support routine thyroid cancer screening based solely on prior COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1926365","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:05Z","timestamp":1786422005000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term risk of incident thyroid cancer after COVID-19 in patients with thyroid disorder: a multicenter propensity score\u2013matched cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Ming","family":"Yew","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center","place":["Tainan, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, E-Da Hospital, I-Shou University","place":["Kaohsiung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Hsun","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Hospital, Liouying","place":["Tainan, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2024.02.003","article-title":"Management of small papillary thyroid cancers","volume":"104","author":"Fields","year":"2024","journal-title":"Surg Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0039","article-title":"Geospatial and temporal analysis of thyroid cancer incidence in a rural population","volume":"25","author":"Hanley","year":"2015","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02588-8","article-title":"Triggers of thyroid cancer diagnosis: a systematic review and meta-analysis","volume":"72","author":"Lincango-Naranjo","year":"2021","journal-title":"Endocrine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00884","article-title":"Differentiated thyroid cancer, from active surveillance to advanced therapy: toward a personalized medicine","volume":"10","author":"Matrone","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","first-page":"66","article-title":"Risk factors for thyroid cancer: what do we know so far","volume":"59","author":"Bogovi\u0107 Crn\u010di\u0107","year":"2020","journal-title":"Acta Clin Croat"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdx088","article-title":"Attributable risk fraction of four lifestyle risk factors of thyroid cancer: a meta-analysis","volume":"40","author":"Sadeghi","year":"2018","journal-title":"J Public Health (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2024.2419488","article-title":"Associations between obesity and risk of thyroid cancer: a meta-analysis of cohort studies","volume":"77","author":"Hisan","year":"2025","journal-title":"Nutr Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/med.0000000000000570","article-title":"Hashimoto's thyroiditis as a risk factor for thyroid cancer","volume":"27","author":"Feldt-Rasmussen","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14069","article-title":"Thyroid nodules as a risk factor for thyroid cancer in patients with Graves' disease: a systematic review and meta-analysis of observational studies in surgically treated patients","volume":"91","author":"Papanastasiou","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/etj-23-0055","article-title":"The role of Graves' disease in the development of thyroid nodules and thyroid cancer","volume":"12","author":"Soares","year":"2023","journal-title":"Eur Thyroid J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102724","article-title":"Risk and prognosis of thyroid cancer in patients with Graves' disease: an umbrella review","volume":"15","author":"Palella","year":"2023","journal-title":"Cancers (Bsl)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zraa014","article-title":"Prevalence and risk factors for thyroid cancer in patients with multinodular goitre","volume":"5","author":"Apostolou","year":"2021","journal-title":"BJS Open"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3363-1","article-title":"Risk of thyroid cancer in patients with thyroiditis: a population-based cohort study","volume":"21","author":"Liu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B14","article-title":"Inflammation in thyroid oncogenesis","volume":"2","author":"Liotti","year":"2012","journal-title":"Am J Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2174\/092986710792927804","article-title":"The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential","volume":"17","author":"Bozec","year":"2010","journal-title":"Curr Med Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential Malignant transformation","volume":"19","author":"Ralli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1331452","article-title":"Editorial: The thyroid and Covid-19, volume II","volume":"14","author":"Brenta","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/med.0000000000000654","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update","volume":"28","author":"Brix","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02650-z","article-title":"Thyroid cancer and COVID-19: experience at one single thyroid disease referral center","volume":"72","author":"Prete","year":"2021","journal-title":"Endocrine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01436-w","article-title":"Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis","volume":"44","author":"Rotondi","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/etj-22-0074","article-title":"Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series","volume":"11","author":"Macedo","year":"2022","journal-title":"Eur Thyroid J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09615-z","article-title":"Impact of COVID-19 on the thyroid gland: an update","volume":"22","author":"Scappaticcio","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-024-00581-8","article-title":"Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis","volume":"19","author":"Letafati","year":"2024","journal-title":"Infect Agent Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1564726","article-title":"Editorial: Infection-mediated inflammation that promotes cancer initiation and\/or progression","volume":"12","author":"Sayed","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/biology10060533","article-title":"Pathogens and carcinogenesis: a review","volume":"10","author":"Hatta","year":"2021","journal-title":"Biol (Bsl)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221082898","article-title":"Potential relationships between COVID-19 and the thyroid gland: an update","volume":"50","author":"Naguib","year":"2022","journal-title":"J Int Med Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101742","article-title":"COVID-induced thyroid autoimmunity","volume":"37","author":"Brancatella","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000511872","article-title":"Subacute thyroiditis from COVID-19 infection: a case report and review of literature","volume":"9","author":"Khatri","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-020-00230-w","article-title":"Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic","volume":"20","author":"Ruggeri","year":"2021","journal-title":"Hormones (Athens)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2024.100255","article-title":"Association of COVID-19 with thyroid dysfunction and autoimmune thyroid disease: a retrospective cohort study","volume":"9","author":"Di","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081933","article-title":"Association between COVID-19 infection and thyroid cancer development: a retrospective cohort study using the TriNetX database","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s598443","article-title":"Association of dexmedetomidine exposure with long-term mortality in patients with dialysis-requiring acute kidney injury: a propensity score-matched retrospective cohort study","volume":"20","author":"Hung","year":"2026","journal-title":"Drug Des Devel Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2026.1755607","article-title":"Vitamin D deficiency and risk of heart failure in patients with obstructive sleep apnea: a cohort analysis","volume":"13","author":"Chang","year":"2026","journal-title":"Front Nutr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1718261","article-title":"Association between iron deficiency anemia and risk of hearing loss among female patients: a multi-institutional cohort study","volume":"12","author":"Chen","year":"2025","journal-title":"Front Nutr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0116","article-title":"The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries","volume":"25","author":"Vaccarella","year":"2015","journal-title":"Thyroid"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2022.0229","article-title":"Thyroidal angiotensin-converting enzyme 2 protein expression and thyroid function tests in patients with COVID-19: results from a retrospective case series and a prospective cohort study","volume":"33","author":"Koehler","year":"2023","journal-title":"Thyroid"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1255727","article-title":"Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment","volume":"14","author":"Attiq","year":"2023","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"key":"B42","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-025-09332-0","article-title":"Respiratory viral infections awaken metastatic breast cancer cells in lungs","volume":"645","author":"Chia","year":"2025","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1337406","article-title":"New-onset autoimmune disease after COVID-19","volume":"15","author":"Hileman","year":"2024","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102154","article-title":"Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study","volume":"63","author":"Peng","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1926365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:06Z","timestamp":1786422006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1926365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":45,"alternative-id":["10.3389\/fendo.2026.1926365"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1926365","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"1926365"}}